Suppr超能文献

门静脉海绵样变胆管病的发病机制:是侧支循环压迫还是门静脉血栓形成时胆管的缺血性损伤?

Pathogenesis of Portal Cavernoma Cholangiopathy: Is it Compression by Collaterals or Ischemic Injury to Bile Ducts During Portal Vein Thrombosis?

作者信息

Puri Pankaj

机构信息

Department of Gastroenterology, Army Hospital (Research and Referral), Dhaula Kuan, New Delhi 110010, India.

出版信息

J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S27-33. doi: 10.1016/j.jceh.2013.05.015. Epub 2014 Jan 2.

Abstract

The pathogenesis of portal cavernoma cholangiopathy (PCC) is important as it can impact the choice of treatment modalities. PCC consists of a reversible component, which resolves by decompression of collaterals as well as a fixed component, which persists despite the decompression of collaterals. The reversible component is due to compression by large collaterals located adjacent to the bile duct as well as possibly intracholedochal varices. The fixed component is likely to be due to ischemia at the time of portal vein thrombosis, local ischemia by compression as well as encasement by a solid tumor-like cavernoma comprising of fibrous hilar mass containing multiple tiny collateral veins rather than markedly enlarged portal collaterals. Although cholangiographic abnormalities in portal hypertension are common, the prevalence of symptomatic PCC is low. This is likely to be related to the cause of portal hypertension, the duration of portal hypertension and possibly the pattern of occlusion of the splenoportal axis. There may possibly be higher prevalence of symptomatic PCC in extension of the thrombosis to the splenomesentric veins.

摘要

门静脉海绵样变性胆管病(PCC)的发病机制很重要,因为它会影响治疗方式的选择。PCC由一个可逆成分和一个固定成分组成,可逆成分通过侧支循环减压而缓解,而固定成分即使在侧支循环减压后仍持续存在。可逆成分是由于位于胆管附近的大侧支循环以及可能的胆管内静脉曲张压迫所致。固定成分可能是由于门静脉血栓形成时的缺血、压迫导致的局部缺血以及由包含多个微小侧支静脉而非明显扩张的门静脉侧支的纤维性肝门肿块样海绵状瘤包绕所致。尽管门静脉高压中的胆管造影异常很常见,但有症状的PCC患病率较低。这可能与门静脉高压的病因、门静脉高压的持续时间以及脾门静脉轴的闭塞模式有关。在血栓延伸至脾肠系膜静脉时,有症状的PCC患病率可能更高。

相似文献

3
Portal cavernoma cholangiopathy-clinical characteristics.门静脉海绵样变相关性胆管病——临床特征
J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S34-6. doi: 10.1016/j.jceh.2013.05.014. Epub 2013 Oct 22.
5
Imaging of portal cavernoma cholangiopathy.门静脉海绵样变性胆管病的影像学表现
J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S44-52. doi: 10.1016/j.jceh.2013.07.004. Epub 2013 Sep 27.
8
Surgical management of portal cavernoma cholangiopathy.门静脉海绵样变性胆管病的外科治疗
J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S77-84. doi: 10.1016/j.jceh.2013.07.005. Epub 2013 Sep 17.
10
Histological Changes in Portal Cavernoma Cholangiopathy.门静脉海绵样变性胆管病的组织学变化
Diagnostics (Basel). 2023 Jan 25;13(3):436. doi: 10.3390/diagnostics13030436.

引用本文的文献

5
Management of splanchnic vein thrombosis.内脏静脉血栓形成的管理。
JHEP Rep. 2023 Jan 3;5(4):100667. doi: 10.1016/j.jhepr.2022.100667. eCollection 2023 Apr.
8
Portal biliopathy.门静脉性肝病
World J Gastroenterol. 2016 Sep 21;22(35):7973-82. doi: 10.3748/wjg.v22.i35.7973.

本文引用的文献

1
Collateral pathways in portal hypertension.门静脉高压症中的侧支循环途径。
J Clin Exp Hepatol. 2012 Dec;2(4):338-52. doi: 10.1016/j.jceh.2012.08.001. Epub 2012 Dec 16.
8
Portal hypertensive biliopathy: Can we prevent it?
J Indian Assoc Pediatr Surg. 2010 Jan;15(1):1. doi: 10.4103/0971-9261.69132.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验